Comparison of anti-SARS-CoV-2 IgG and IgA antibody responses post complete vaccination, 7 months later and after 3rd dose of the BNT162b2 vaccine in healthy adults
Waldemar Rastawicki, Grzegorz Juszczyk, Rafał Gierczyński, Aleksandra Anna Zasada
Topics & Concepts
MedicineVaccinationBooster doseAntibodyBooster (rocketry)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)ImmunologyImmunoglobulin GVirologyTiterInternal medicineInfectious disease (medical specialty)DiseaseAstronomyPhysicsSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studiesvaccines and immunoinformatics approaches